Company Filing History:
Years Active: 2017
Title: The Innovations of Daniel Canterbury
Introduction
Daniel Canterbury is an accomplished inventor based in Groton, CT (US). He has made significant contributions to the field of pharmacology, particularly through his work on prostaglandin receptors. With a focus on developing antagonists for the prostaglandin EP3 receptor, his innovations aim to address various medical needs.
Latest Patents
Daniel Canterbury holds 1 patent for his invention titled "Antagonists of Prostaglandin EP3 Receptor." This patent provides detailed information on the antagonists, the processes to create them, and methods for administering these compounds to mammals in need of treatment.
Career Highlights
Canterbury is currently employed at Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to collaborate with some of the brightest minds in the industry, contributing to advancements in drug development and therapeutic solutions.
Collaborations
Throughout his career, Daniel has worked alongside notable colleagues such as Kevin Barry Bahnck and David James Edmonds. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Daniel Canterbury's contributions to the field of pharmacology through his patent on prostaglandin EP3 receptor antagonists exemplify the impact of dedicated inventors in advancing medical science. His work continues to inspire future innovations in the industry.